Pharmaceutical News

RSS

Schwarzenegger signs AIDS Pharmacy Bill

The AIDS Healthcare Foundation (AHF) has praised Governor Schwarzenegger for signing AB 1367 (Darrell Steinberg, D, Sacramento John Laird, D, Santa Cruz).

29 Sep 2004

Chiron CEO to appear before the U.S. Senate Special Committee on Aging

Chiron Corporation announced that president and chief executive officer Howard Pien will appear before the U.S. Senate Special Committee on Aging in Washington, D.C., today in a hearing titled, "Combating the Flu: Keeping Seniors Alive."

28 Sep 2004

New capsule, made from fish gelatin, should end fears of viral infections such as BSE and vCJD

An alternative to mammalian gelatin for use in pharmaceutical soft capsules has been discovered by researchers at the School of Pharmacy and Chemistry at Liverpool John Moores University.

28 Sep 2004

Half of sildenafil samples purchased on the internet were fake

Around half of the Viagra samples purchased on the Internet were counterfeit, according to researchers who are today announcing a new technique that detects counterfeit medicines at the British Pharmaceutical Conference.

27 Sep 2004

New drug application to market ramelteon for insomnia

Takeda Global Research & Development Center announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) to market ramelteon (TAK-375), its investigational drug for insomnia.

26 Sep 2004

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of Ranbaxy Laboratories Limited of New Delhi, India, announced today that RLL has received approval from the U. S. Food and Drug Administration to manufacture and market Loratadine and Pseudoephedrine Sulfate Extended Release Tablets

26 Sep 2004

Drug companies and FDA crack down on Canadian drug importation to protect profits

With an election on the horizon, and Canadian pharmacies proving to be as safe as U.S. counterparts, the Food and Drug Administration and big pharma are increasing efforts to prevent Canadian drug importation.

26 Sep 2004

Drug shortages are having major negative effects on patient care and hospital costs

A study to be published in the October 1, 2004, issue of the American Journal of Health-System Pharmacy finds that ongoing drug shortages are having far-ranging, negative effects on patient care and hospital costs.

26 Sep 2004

Palladone approved for pain relief

The Food and Drug Administration (FDA) has approved Palladone (hydromorphone hydrochloride) capsules for the management of persistent moderate to severe pain in patients requiring continuous around-the-clock opioid pain relief for an extended period of time.

26 Sep 2004

New combination of drugs results in fewer incidences of rejection in liver transplant patients

“The big advantage [of this combination of drugs] is that the incidence of rejection is significantly decreased,” he says. “These results could change the standard of care for liver transplant recipients.”

23 Sep 2004

PA Consulting sells drug delivery venture, Meridica, to Pfizer

Pfizer and PA Consulting Group have announced the signing of a transaction in which Pfizer will purchase the remaining 90% ownership of Meridica Limited

23 Sep 2004

Glaxo drops appeal in AIDS drug pricing case

A landmark South African legal complaint against British drug maker GlaxoSmithKline (GSK) over its AIDS drug pricing and policies in that country will proceed after GSK dropped its public and repeated vows to appeal a decision allowing the case to go forward.

22 Sep 2004

GlaxoSmithKline has granted a voluntary licence to Cosmos Limited for the manufacture and sale of antiretrovirals

GlaxoSmithKline currently sells zidovudine (sold as Retrovir®), lamivudine (sold as Epivir®) and the combination of the two molecules (sold as Combivir®) across the region.

22 Sep 2004

Aventis Pasteur to manufacture and store 2 million doses of avian influenza H5N1 vaccine

HHS Secretary Tommy G. Thompson has announced the awarding of a contract to Aventis Pasteur Inc. to manufacture and store 2 million doses of avian influenza H5N1 vaccine

22 Sep 2004

Data suggests potential role of Quadramet in conjunction with chemotherapy for the treatment of acute myeloid leukemia

Cytogen Corporation today announced the presentation of new data relating to its lead therapeutic product Quadramet (samarium Sm-153 lexidronam injection) during the 36th Congress of the International Society of Pediatric Oncology (SIOP).

20 Sep 2004

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Isis Pharmaceuticals announced today that Eli Lilly and Company licensed LY2275796, a second-generation antisense anti-cancer drug candidate for clinical development.

20 Sep 2004

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.

20 Sep 2004

European positive for Cymbalta and Xeristar

Eli Lilly and Company and Boehringer Ingelheim have announced that the Committee for Medicinal Products in Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of duloxetine for the treatment of major depressive episodes.

20 Sep 2004

Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine

Dutch biotechnology company Crucell and the International AIDS Vaccine Initiative (IAVI) have signed an exclusive license agreement to develop an AIDS vaccine based on Crucell’s AdVac® technology.

20 Sep 2004

Wyeth supports FDA recommendation to strengthen antidepressant labeling

Statement by Wyeth Pharmaceuticals supporting the U.S. Food and Drug Administration (FDA) Joint Advisory Committee’s recommendation to strengthen the product labels across the antidepressant category regarding use in the pediatric population.

16 Sep 2004

Pharmaceutical News

Schwarzenegger signs AIDS Pharmacy Bill

Chiron CEO to appear before the U.S. Senate Special Committee on Aging

New capsule, made from fish gelatin, should end fears of viral infections such as BSE and vCJD

Half of sildenafil samples purchased on the internet were fake

New drug application to market ramelteon for insomnia

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Drug companies and FDA crack down on Canadian drug importation to protect profits

Drug shortages are having major negative effects on patient care and hospital costs

Palladone approved for pain relief

New combination of drugs results in fewer incidences of rejection in liver transplant patients

PA Consulting sells drug delivery venture, Meridica, to Pfizer

Glaxo drops appeal in AIDS drug pricing case

GlaxoSmithKline has granted a voluntary licence to Cosmos Limited for the manufacture and sale of antiretrovirals

Aventis Pasteur to manufacture and store 2 million doses of avian influenza H5N1 vaccine

Data suggests potential role of Quadramet in conjunction with chemotherapy for the treatment of acute myeloid leukemia

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

European positive for Cymbalta and Xeristar

Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine

Wyeth supports FDA recommendation to strengthen antidepressant labeling

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News